• dwocx
• Mutual Fund
• US Stocks
• Large Growth

BNY Mellon Research Growth Fund, Inc. Class C

Expenses: 1.78% (Better than 0% of similar funds)

This is a bad choice for a Large Growth US Stocks fund. See why »

• etgax
• Mutual Fund
• Bond
• Municipal Bond

Eaton Vance Georgia Municipal Income Fund Class A

Expenses: 0.70% (Better than 1% of similar funds)

This is a bad choice for a Municipal Bond Bond fund. See why »

• fra
• Mutual Fund
• Bond
• High Yield Bond

BlackRock Floating Rate Income Strategies Fund Inc

Expenses: 2.20% (Better than 0% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• ncicx
• Mutual Fund
• Bond
• High Yield Bond

New Covenant Income Fund

Expenses: 0.80% (Better than 1% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• bbp
• ETF
• Sector Equity
• Healthcare

Virtus LifeSci Biotech Products ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• jpecx
• Mutual Fund
• US Stocks
• Large Growth

JPMorgan Tax Aware Equity Fund Class C

Expenses: 1.44% (Better than 0% of similar funds)

This is a bad choice for a Large Growth US Stocks fund. See why »

• bapax
• Mutual Fund
• Allocation
• Target-Date

Blackrock Lifepath Smart Beta 2060 Fund Investor A Shares

Expenses: 0.35% (Better than 1% of similar funds)

This is a bad choice for a Target-Date Allocation fund. See why »

• baiax
• Mutual Fund
• Bond
• Total US Bond Market

Brown Advisory Intermediate Income Advisor Shares

Expenses: 0.78% (Better than 1% of similar funds)

This is a bad choice for a Total US Bond Market Bond fund. See why »

• nhiax
• Mutual Fund
• Bond
• High Yield Bond

Neuberger Berman High Income Bond Fund Class A

Expenses: 1.12% (Better than 0% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• jpfsx
• Mutual Fund
• US Stocks
• Large Growth

JPMorgan Equity Focus Fund Class I

Expenses: 0.84% (Better than 1% of similar funds)

This is a bad choice for a Large Growth US Stocks fund. See why »

• fax
• Mutual Fund
• Bond
• High Yield Bond

Aberdeen Asia-Pacific Income Fund Inc

Expenses: 2.84% (Better than 0% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• fxp
• ETF
• Alternative
• Inverse

ProShares UltraShort FTSE China 50

Expenses: 0.95% (Better than 0% of similar funds)

This is a bad choice for a Inverse Alternative fund. See why »

• sghax
• Mutual Fund
• Bond
• High Yield Bond

DWS Global High Income Fund - Class A

Expenses: 0.85% (Better than 1% of similar funds)

This is a bad choice for a High Yield Bond Bond fund. See why »

• atecx
• Mutual Fund
• Allocation
• Total World

AB Sustainable Global Thematic Fund Class C

Expenses: 2.01% (Better than 0% of similar funds)

This is a bad choice for a Total World Allocation fund. See why »

• faumx
• Mutual Fund
• Bond
• Municipal Bond

Frost Municipal Bond Fund Investor Class Shares

Expenses: 0.68% (Better than 1% of similar funds)

This is a bad choice for a Municipal Bond Bond fund. See why »

• chccx
• Mutual Fund
• US Stocks
• Mid-Cap Growth

AB Discovery Growth Fund Class C

Expenses: 1.72% (Better than 0% of similar funds)

This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »

• pvpax
• Mutual Fund
• Allocation
• Target-Date

PIMCO RealPath Blend 2040 Fund Class A

Expenses: 0.56% (Better than 0% of similar funds)

This is a bad choice for a Target-Date Allocation fund. See why »

• lbfix
• Mutual Fund
• US Stocks
• Mid-Cap Growth

ClearBridge Select Fund Class I

Expenses: 1.16% (Better than 1% of similar funds)

This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »

• arttx
• Mutual Fund
• US Stocks
• Large Growth

Artisan Focus Fund Investor Shares

Expenses: 1.37% (Better than 0% of similar funds)

This is a bad choice for a Large Growth US Stocks fund. See why »

• fphax
• Mutual Fund
• Sector Equity
• Healthcare

Fidelity® Select Pharmaceuticals Portfolio

Expenses: 0.77% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »